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Progression of Aortic Calcification Is Associated With
Metacarpal Bone Loss During Menopause
A Population-Based Longitudinal Study
A. Elisabeth Hak, Huibert A.P. Pols, Albert M. van Hemert, Albert Hofman, Jacqueline C.M. Witteman
Abstract—Atherosclerosis and osteoporosis are major causes of morbidity and mortality in postmenopausal women and
have been suggested to be associated. No study has examined whether progression of atherosclerotic calcification is
associated with bone loss. In the present study, we examined progression of aortic calcification, diagnosed by
radiographic detection of calcified deposits in the abdominal aorta, in relation to metacarpal bone loss, as assessed by
metacarpal radiogrammetry, during menopause. Initially premenopausal women (n5236), aged 45 to 57 years at
baseline, were followed for 9 years. We additionally assessed the cross-sectional association between the extent of aortic
calcification and metacarpal bone mass and density in 720 postmenopausal women. Twenty-five percent of women
going through menopause showed progression of aortic calcification. The average loss of metacarpal bone mass among
women with progression of aortic calcification was 3.2 mm2, and their loss of metacarpal bone density was 7.2 mm2 %,
whereas in women without progression of aortic calcification, these losses were 2.0 mm2 and 5.6 mm2 %, respectively,
adjusted for age and years of follow-up (P,0.05). Additional adjustment for age at menopause, body mass index, blood
pressure, smoking, diabetes mellitus, and use of hormone replacement therapy, thiazide, and loop diuretics did not
influence these results. In postmenopausal women, a graded inverse cross-sectional association between the extent of
aortic calcification and metacarpal bone mass and density was found. In conclusion, our results indicate that progression
of atherosclerotic calcification is associated with increased bone loss in women during menopause. (Arterioscler
Thromb Vasc Biol. 2000;20:1926-1931.)
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Cardiovascular disease and osteoporosis are major causesof morbidity and mortality in postmenopausal women1,2
and are generally considered unrelated. Several studies,
however, indicate that atherosclerosis and osteoporosis are
associated.3–10 Calcification is a common feature of athero-
sclerotic plaques and is regulated in a way similar to bone
mineralization.11–16 The relation of vascular calcification to
the pathogenesis of atherosclerosis and plaque rupture is not
clear yet, but data indicate that moderate calcification of
plaques contributes to vascular morbidity and mortality.17–20
Several cross-sectional studies have been conducted on the
association between atherosclerotic calcification and osteo-
porosis among elderly women.3–8,21–23 Most of these studies
found an association,3–8 although some did not.21–23 Potential
confounding factors other than age have not been taken into
account in most of these studies.3–5,8,21,22 No study examined
whether progression of atherosclerotic calcification is asso-
ciated with bone loss. Because the prevalence of atheroscle-
rosis and osteoporosis increases from menopause onward,24,25
the change from the premenopausal to the postmenopausal
state may be an appropriate period to study this association
longitudinally.
In the present population-based study, we examined the
association between progression of aortic calcification and
metacarpal bone loss during menopause in 236 women. In
addition, we studied the cross-sectional association between
the extent of aortic calcification and metacarpal bone mass
and density in 720 postmenopausal women.
Methods
Population
Between 1975 and 1978, a population-based study on risk factors for
chronic diseases was conducted in the Dutch town of Zoetermeer.
Inhabitants of 2 districts were invited for a medical examination. In
1985, all female participants aged 45 to 64 years at baseline were
invited for a follow-up examination. Details of that study have been
previously published.25,26 The response rate of the women at baseline
was 77%. Of 1167 women invited for the follow-up study, 71 had
died and 87 had moved away. Of the remaining women, 855 (85%)
were reexamined.
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Measurement of Aortic Calcification
Aortic calcification was diagnosed by radiographic detection of
calcified deposits in the abdominal aorta.26 At baseline and at
follow-up, lateral abdominal films (T12-S1) were made from a fixed
distance while the subject was seated. Aortic calcifications were
considered present when linear densities were seen in an area parallel
and anterior to the lumbar spine (L1-L4). Baseline and follow-up
values for the extent of calcification were scored according to the
length of the involved area (#1 cm, 2 to 5 cm, 6 to 10 cm, and .10
cm). In the analyses, we considered the first 2 classes as mild
calcification and the third and fourth classes as advanced
calcification.
Progression of calcification was defined as the occurrence of new
calcifications or enlargement of the calcified area present at baseline.
Baseline and follow-up films were examined in pairs. The extent of
progression was graded, but because of the relatively small numbers
in the categories, we combined severity grades into 2 groups:
progression absent and progression present. No subject showed a
decrease in the extent of aortic calcification.
All films were examined by 2 independent observers without
knowledge of the metacarpal bone mass and density of the subjects.
Before the scoring, a sample of the films was read by the 2 observers
simultaneously so as to reach agreement on interpretation of the
scoring protocol. Observers were aware of the date of the radio-
graphs. If there were differences between observers regarding
readings, films were reviewed by both observers simultaneously so
as to reach consensus. The score that was agreed upon by both
observers was recorded. The percentage of agreement for absence
versus presence of progression was 88%, and the k statistic was 0.74.
The validity of radiographic assessment of aortic intimal calcifi-
cation was studied by comparisons made on necropsy material. The
method was shown to be highly specific, and in most cases, visible
calcification represented advanced atherosclerosis.27 A comparison
study with computed tomography in 56 unselected elderly subjects
showed that calcifications that were detected on the abdominal x-ray
in 32 subjects were independently shown to be located in the aorta on
the corresponding CT images in all but 1 subject.26 Moreover, aortic
calcification is known to be associated with cardiovascular disease
risk factors26,28 and atherosclerosis at other sites29 and to predict
cardiovascular morbidity and mortality.18,19 Comparison of roent-
genographic aortic calcification with coronary artery calcium as
detected by electron beam tomography within 457 subjects showed
that aortic calcification was present in 3.9%, 13.7%, and 31.5% of
the subjects within the lowest, the middle, and the highest tertile of
coronary artery calcium, respectively (P for trend,0.001, adjusted
for age and sex). These results indicate that aortic calcification is
strongly related to coronary calcification.
Metacarpal Radiogrammetry
Anteroposterior radiographs of the hands were used for measure-
ments of the cortical thickness of metacarpals II, III, and IV of both
hands. At baseline and at follow-up, measurements of the outer
diameter (D) and the medullar diameter (d) of the metacarpal bones
were conducted at the midshaft with the use of a 37 magnifying
loupe with an accuracy of 0.01 mm. The metacarpal cortical area
(MCA) was calculated as the mean value of D22d2 for 6 metacarpals.
As a standardization for differences in body size, the relative cortical
area (RCA) was calculated. This was achieved by expressing the
MCA as a percentage of the size of the metacarpal bone:
100%3(D22d2)/D2 for each metacarpal bone.30,31 The mean value of
the 6 metacarpals was used for the analyses. The MCA and RCA can
be interpreted as indicators of bone mass and bone density, respec-
tively. For the MCA and the RCA, the total loss during follow-up
was calculated by subtracting the baseline measurements from those
at follow-up. The observers measuring the metacarpal bone mass and
density were unaware of the aortic calcification score of the subjects.
We estimated the measurement precision of metacarpal radiogram-
metry in 100 duplicate measurements. The mean intraindividual
standard deviation of a duplicate measurement was 1.9 mm2 (4% of
the initial mean value) for MCA and 2.5 mm2 % (3% of the initial
mean value) for RCA, which is sufficient to allow inferences
concerning bone loss after a 9-year period. In women, the mineral
content of the metacarpals correlates well with that at other periph-
eral skeletal bone sites (r ranges from 0.75 to 0.96).32 The accuracy
of the measurement was demonstrated by Exton-Smith et al,33 who
found a correlation of 0.85 between the mineral content of the
metacarpal cortical area and the ash mineral content of the metacar-
pal bones.
Menopausal State
Menopausal state was assessed by a self-administered questionnaire
that asked whether the menses had stopped and, if so, at what age and
the reason for their cessation (natural or artificial). The type of
artificial menopause was ascertained during an interview by a doctor.
Postmenopausal state was defined as no menstruation for at least 1
year.
Assessment of Covariates
Assessment of covariates was similar at baseline and at follow-up.
Height and weight were measured without shoes and with indoor
clothing. Body mass index was calculated (weight/height2). Blood
pressure was measured with a random zero sphygmomanometer with
the subject seated. The mean of 2 readings was reported. Serum total
cholesterol at baseline was measured by an automatic enzymatic
method. During follow-up, a modified reagent was used (CHOD/
PAP High Performance, Boehringer-Mannheim). Information on
smoking habits and medical history was obtained by a self-
administered questionnaire, which was checked during an interview
by the study physician. Diabetes mellitus was considered present
when it was reported in the questionnaire and confirmed during the
interview with the physician. Subjects were asked to bring their
current medication to the research center, where treatments were
noted.
Population for Analyses
Of the 855 women examined at follow-up, menstruation had ceased
for ,1 year in 7 women, and for 11 women, information on
menopausal state was missing. Because films were missing or not
readable, information on aortic calcification and/or metacarpal bone
density was missing in 45 women, leaving 792 postmenopausal
women. Of these women, 282 were premenopausal at baseline. Data
on progression of aortic calcification or bone loss were missing in 27
women. Age at menopause could not be ascertained for 19 women,
leaving 236 women for the analyses of the association between
progression of aortic calcification and bone loss. The mean duration
of follow-up for these women was 8.960.8 years. For the cross-
sectional analyses in postmenopausal women at follow-up, we
excluded women with missing information on age at menopause only
if their age at follow-up was ,60 years (n572), because we assumed
elderly women to be postmenopausal. This left 720 postmenopausal
women for the cross-sectional analyses at follow-up.
Data Analysis
Initially, we compared continuous baseline characteristics between
premenopausal women with and without progression of aortic
calcification during follow-up by use of a general linear model,
adjusted for age. Dichotomous variables were compared by a x2 test.
We used a general linear model to compute and compare adjusted
mean values of metacarpal bone loss in categories of progression of
aortic calcification. The cross-sectional association between aortic
calcification and metacarpal bone mass and density in all postmeno-
pausal women at follow-up was assessed by linear regression
analysis with MCA and RCA as dependent variables and the variable
indicating the extent of aortic calcification (no, mild, or advanced) as
an independent variable. A test of significance for the coefficient of
this ordinal variable was considered to be a test for trend. Adjusted
mean values of bone mass and density in categories of aortic
calcification were computed by use of a general linear model.
Statistical significance was considered to be present at P,0.05.
SPSS 8.0 for Windows was used for analyses.
Results
The characteristics of the study population are shown in
Table 1. The age of premenopausal women at baseline ranged
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from 45.0 to 56.8 years. Mild aortic calcification was present
in 25 premenopausal women at baseline, whereas only 1
woman showed advanced aortic calcification. Metacarpal
bone mass (MCA) and density (RCA) decreased during
follow-up, by 4.5% and 7.4%, respectively. The age of all
postmenopausal women at follow-up ranged from 53.5 to
76.2 years.
During follow-up, progression of aortic calcification was
observed in 59 women going through menopause (25%). No
subject showed a decrease in the extent of aortic calcification.
Compared with premenopausal women without progression
of aortic calcification during follow-up, women with progres-
sion of aortic calcification had a higher systolic blood
pressure (136 versus 130 mm Hg, respectively; P50.03), a
higher serum cholesterol (6.2 versus 5.7 mmol/L, respec-
tively; P,0.001), both adjusted for age, and smoked more
(56% versus 31%, respectively; P50.001) at baseline. No
significant differences were seen in other cardiovascular
disease risk factors.
Among women with progression of aortic calcification, the
average loss of initial metacarpal bone mass was 6.1%; their
average loss of initial metacarpal bone density was 8.9%. In
women without progression of aortic calcification, these
losses were 3.9% and 6.9%, respectively. Additional adjust-
ment for potential confounding factors did not influence these
results (Table 2), nor did additional adjustment for cardio-
vascular disease history (data not shown). In women already
postmenopausal at baseline, there was no association between
progression of aortic calcification and metacarpal bone loss
during follow-up (data not shown).
We detected an inverse, graded, cross-sectional association
between extent of aortic calcification and metacarpal bone
mass and density in all postmenopausal women at follow-up,
adjusted for age (Table 3). Again, additional adjustment for
potential confounders did not influence the results (Table 3),
nor did additional adjustment for cardiovascular disease
history (data not shown).
TABLE 1. Baseline and Follow-Up Characteristics of the Study Population
Premenopausal at Baseline
and Postmenopausal at
Follow-Up
All Postmenopausal
at Follow-Up
(n5720)
Baseline
(n5236)
Follow-Up
(n5236)
Age, y 49.062.5 57.962.6 62.965.6
Height, m 1.6460.06 1.6360.06 1.6260.06
Weight, kg 67.269.7 69.2611.3 69.0610.4
Body mass index, kg/m2 25.163.4 26.164.2 26.363.9
Systolic blood pressure, mm Hg 132619 141621 145621
Diastolic blood pressure, mm Hg 82611 8369 82610
Serum cholesterol, mmol/L 5.860.9 7.061.2 7.261.3
Current smokers, % 37 28 24
Former smokers, % 27 36 31
Diabetes mellitus, % 1 4 6
Use of hormone replacement therapy, % 0.4 3 1
Use of thiazide diuretics, % 13 14 15
Use of loop diuretics, % 0.4 2 4
Cardiovascular disease history, % 1.7 3.4 3.5
Mild aortic calcification, % 11 16 23
Advanced aortic calcification, % 0.4 11 20
MCA, mm2 51.566.6 49.266.5 47.966.5
RCA, mm2, % 81.266.8 75.266.5 71.768.0
Values are mean6SD or percentages.
TABLE 2. Bone Loss According to Progression of Aortic
Calcification of 236 Women Premenopausal at Baseline and
Going Through Menopause During Follow-Up
Bone Loss
Aortic Calcification
P
Progression
(n559)
No Progression
(n5177)
Change in MCA,* mm2 23.260.4 22.060.2 0.01
Change in MCA,† mm2 % 23.560.4 22.060.2 ,0.01
Change in RCA,* mm2 27.260.6 25.660.3 0.02
Change in RCA,† mm2 % 27.560.6 25.560.3 ,0.01
Values are mean6SE.
*Adjusted for age and years of follow-up.
†Adjusted for age, years of follow-up, age at menopause, body mass index
at baseline, change in body mass index during follow-up, systolic blood
pressure at baseline, change in systolic blood pressure during follow-up,
smoking at baseline (never, former, or current), stopping and starting of
smoking during follow-up, diabetes mellitus at baseline, diabetes mellitus
developed during follow-up, and use of hormone replacement therapy, thiazide,
and loop diuretics at baseline and at follow-up. Because of missing values, the
number of subjects is not exactly the same.
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Discussion
Our results show that during menopause, women with pro-
gression of aortic calcification lose more metacarpal bone
than women without progression of aortic calcification. In
postmenopausal women, a higher degree of aortic calcifica-
tion is associated with a lower metacarpal bone mass and
density.
When interpreting our results, some methodological
issues should be taken into account. An advantage of the
present study is the fact that the association between
progression of aortic calcification and bone loss was
studied during menopause, the period from which the
prevalence of atherosclerosis and osteoporosis increas-
es.24,25 The prevalence of hormone replacement therapy
use in our population was low, which was common in the
Netherlands during the period the present study was
conducted.34 We measured aortic calcification radiograph-
ically. We assume that this is intimal calcification, which
is clearly distinguishable from medial calcification.35 A
limitation of our measurement of aortic calcification is the
fact that it detected progression in a linear manner,
whereas in fact it may have been circumferential. How-
ever, we assume that errors in the measurement of pro-
gression of aortic calcification and bone loss occurred
randomly, which means that, if anything, we underesti-
mated the association between progression of aortic calci-
fication and bone loss. Although the density of calcifica-
tion may be relevant with respect to plaque vulnerability
and the subsequent onset of acute coronary events, the
present study does not provide data on the density of
calcification. No woman showed a decrease in the extent of
aortic calcification. However, the fact that readers were
aware of dates of the radiographs could have biased them
against the detection of decreased calcification. Lack of
information contributed to loss of data. We assume that the
association between progression of aortic calcification and
metacarpal bone loss will not differ between subjects with
or without complete availability of data, making selection
bias unlikely.
We are the first to describe an association between pro-
gression of atherosclerotic calcification and bone loss in
women during menopause. The results of the present study
are in line with those previous studies that showed a cross-
sectional association between bone mineral density and aortic
calcification,3–6 carotid plaques,7 and coronary calcification8
among elderly women. Most of the reported studies, however,
did not adjust for potential confounding factors apart from
age.3–5,8,21,22 Vogt et al23 found an association between aortic
calcification and bone mineral density at 2 of the 5 measured
sites, which remained after adjustment for potential con-
founders. Two studies in elderly women found an adjusted
association between bone mass and density at baseline and
cardiovascular death9 and mortality due to stroke10 during
follow-up.
Atherosclerotic calcification and bone mineralization show
similarities. The mineral within calcified atherosclerotic
plaques is hydroxyapatite, the same mineral found in bone,11
and matrix vesicles, the initial nucleation sites for hydroxy-
apatite mineral in bone, are found in atherosclerotic lesions.12
Calcifying vascular cells appear in many ways similar to
osteoblasts,13 and specific factors and proteins crucial to bone
formation are also present within atherosclerotic lesions. The
bone differentiation factor bone morphogenetic protein-2a
has been found in atherosclerotic lesions,14 and arterial
calcification involves a variety of bone matrix proteins, such
as type-I collagen,15 and the noncollagenous proteins os-
teopontin11 and osteocalcin.16
The association between progression of aortic calcification
and bone loss during menopause may result from a common
etiologic factor, such as estrogen deficiency. Epidemiological
data suggest that estrogen deficiency is a risk factor for
cardiovascular disease and osteoporosis.36,37 Arteries and
bone are target organs for estrogen. Estrogen receptors have
been demonstrated on vascular endothelial and smooth mus-
cle cells,38 osteoblasts,39 and osteoclasts,40 suggesting a direct
effect of estrogen on vascular and bone cells. Whereas all
subjects went through menopause, women with progression
of aortic calcification had more bone loss than women
without progression of aortic calcification, suggesting that
there could be a difference in estrogen loss between subjects.
On the other hand, it may not be estrogen deficiency per se,
but sensitivity to estrogen deficiency (eg, due to variability of
the estrogen receptor gene)41 that is the common etiologic
factor.
Calcium-regulating hormones may be involved in the
association between vascular calcification and osteoporosis.
Parathyroid hormone levels increase with aging.42 Concur-
rently, estrogen deficiency is suggested to increase the
sensitivity of the skeleton to parathyroid hormone43 and to
reduce intestinal calcium absorption.44 Hyperparathyroidism,
which can also be induced in the elderly by vitamin D
deficiency, can on the one hand contribute to bone loss45 and
on the other hand add to soft tissue calcium deposition, in
particular, vascular calcification.
Alternatively, it may not be calcification itself but progres-
sion of the underlying process of atherosclerosis that is
associated with bone loss. Estrogen deficiency may have
indirect effects on arteries and bone by the production of
inflammatory agents, such as interleukin-1 and -6 and tumor
necrosis factor,46 which are involved in atherogenesis47 and
contribute to bone resorption.48–50 Another common factor to
explain the apparent association between atherosclerosis and
bone loss may be the presence of oxidized lipids, which
TABLE 3. Bone Mass and Density According to Aortic
Calcification in 720 Postmenopausal Women at Follow-Up
Bone Measure
Aortic Calcification
P
Trend
No
(n5409)
Mild
(n5167)
Advanced
(n5144)
MCA,* mm2 48.160.3 48.460.5 46.460.5 0.02
MCA,† mm2 % 48.260.3 48.560.5 46.560.5 0.04
RCA,* mm2 72.160.4 71.560.6 70.860.6 0.06
RCA,† mm2 % 72.260.4 71.760.6 71.160.6 0.15
Values are mean6SE.
*Adjusted for age.
†Adjusted for age, body mass index, systolic blood pressure, smoking
(never, former, or current), diabetes mellitus, and use of hormone replacement
therapy, thiazide, and loop diuretics at follow-up. Because of missing values,
the number of subjects is not exactly the same.
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promote atherogenesis51 and inhibit differentiation and min-
eralization of bone cells.52 Plasma homocysteine is a cardio-
vascular risk factor that increases after menopause,53 and
osteoporosis is a common feature in patients with homo-
cystinuria.54 Although no association between homocysteine
and bone density was found in a small group of postmeno-
pausal women,55 hyperhomocysteinemia might be involved
in the association between atherosclerosis and osteoporosis.
In summary, our results indicate that progression of ath-
erosclerotic calcification is associated with bone loss in
women during menopause, suggesting a common etiologic
factor.
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